Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Vita Life Sciences Limited ( (AU:VLS) ) has provided an announcement.
Vita Life Sciences Limited announced the cessation of 3,062 ordinary fully paid securities due to an on-market buy-back, effective December 10, 2025. This move could potentially impact the company’s capital structure and market perception, as buy-backs are often seen as a signal of management’s confidence in the company’s future prospects.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited operates in the health and wellness industry, focusing on the development, manufacturing, and distribution of health supplements and related products. The company is known for its commitment to improving health and well-being through scientifically-backed products.
Average Trading Volume: 13,794
Technical Sentiment Signal: Buy
Current Market Cap: A$131.1M
Find detailed analytics on VLS stock on TipRanks’ Stock Analysis page.